Cite
HARVARD Citation
Joly, F. et al. (n.d.). 2022-RA-605-ESGO Long term quality of life after chemotherapy among rare ovarian cancer survivors: the national gineco case-control Vivrovaire Rare Tumors study. International journal of gynecological cancer. p. A393. [Online].